Single dose pharmacokinetics of tiaprofenic acid. Effects of food and severe renal insufficiency
- PMID: 4026912
Single dose pharmacokinetics of tiaprofenic acid. Effects of food and severe renal insufficiency
Abstract
The single oral dose pharmacokinetics of tiaprofenic acid (Surgam) has been investigated in fasting and non-fasting healthy volunteers (200 and 300 mg) and in fasting patients with severe renal insufficiency (200 mg). A dose independent pharmacokinetics of tiaprofenic acid was shown in fasting healthy volunteers and the following parameters were calculated after administration of 200 mg: tl = 0.53 +/- 0.15 h, tm = 1.28 +/- 0.19 h, cm = 27.1 micrograms/ml, ka = 2.79 +/- 0.93 h-1, lambda 2 = 1.06 +/- 0.14 h-1, t1/2 = 3.0 +/- 0.2 h, AUCl-infinity = 80 +/- 7 mg X h/l, Clt = 43.8 +/- 3.7 ml/min and V beta = 11.1 +/- 0.8 l. A small, but significant positive deviation from linearity was observed with increasing dose for cm and AUCl-infinity in non-fasting healthy volunteers, probably due to a slightly higher bioavailability of the 300 mg formulation in the non-fasting state as compared with the 200 mg formulation. Intake of food decreased cm significantly at both dosage levels from 27.1 to 19.1 micrograms/ml and from 47.9 to 39.1 micrograms/ml for 200 and 300 mg, respectively. The absorption kinetics of tiaprofenic acid was not significantly different in fasting healthy volunteers and in fasting patients with severe renal insufficiency. However, a significant increase in t1/2 and AUCl-infinity to 5.8 +/- 0.9 h and 173 +/- 34 mg X h/l, respectively, and a significant decrease in total body clearance to 25.5 +/- 5.3 ml/min were observed in this category of patients. No correlation was found between creatinine clearance and tiaprofenic acid clearance.
Similar articles
-
Steady state pharmacokinetics of tiaprofenic acid in elderly patients.Arzneimittelforschung. 1985;35(5):875-9. Arzneimittelforschung. 1985. PMID: 4026913
-
Pharmacokinetic profile of benoxaprofen in subjects with normal and impaired renal function, prediction of multiple-dose kinetics.Eur J Rheumatol Inflamm. 1982;5(2):113-23. Eur J Rheumatol Inflamm. 1982. PMID: 7084275
-
Binding of tiaprofenic acid to human sera and isolated serum proteins.Arzneimittelforschung. 1985;35(6):984-7. Arzneimittelforschung. 1985. PMID: 4026926
-
Pharmacokinetics of tiaprofenic acid in infants after a single oral dose.Int J Clin Pharmacol Ther. 1996 Aug;34(8):342-4. Int J Clin Pharmacol Ther. 1996. PMID: 8864796
-
[On the pharmacokinetics of tiaprofenic acid and its possible interactions with acetylsalicylic acid and aluminum hydroxide (author's transl)].Arzneimittelforschung. 1981;31(1):116-20. Arzneimittelforschung. 1981. PMID: 6971108 Clinical Trial. German.
Cited by
-
Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol.Paediatr Drugs. 2001;3(11):817-58. doi: 10.2165/00128072-200103110-00004. Paediatr Drugs. 2001. PMID: 11735667 Review.
-
Pharmacokinetics of tiaprofenic acid in elderly multimorbid patients.Drugs. 1988;35 Suppl 1:53-6. doi: 10.2165/00003495-198800351-00012. Drugs. 1988. PMID: 3359947 No abstract available.
-
Pharmacokinetics of tiaprofenic acid in children after a single oral dose.Eur J Clin Pharmacol. 1991;41(3):251-3. doi: 10.1007/BF00315438. Eur J Clin Pharmacol. 1991. PMID: 1748142
-
Tiaprofenic acid. A reappraisal of its pharmacological properties and use in the management of rheumatic diseases.Drugs. 1995 Dec;50(6):1050-75. doi: 10.2165/00003495-199550060-00010. Drugs. 1995. PMID: 8612471 Review.
-
Effect of diet on the single- and multiple-dose pharmacokinetics of sustained-release ketoprofen.Eur J Clin Pharmacol. 1994;47(4):361-6. doi: 10.1007/BF00191169. Eur J Clin Pharmacol. 1994. PMID: 7875189
MeSH terms
Substances
LinkOut - more resources
Medical